CAS: 87679-37-6; (2S,3Ar,7As)-1-[(2S)-2-[[(2S)-1-Ethoxy-1-Oxo-4-Phenylbutan-2-Yl]Amino]Propanoyl]-2,3,3A,4,5,6,7,7A-Octahydroindole-2-Carboxylic Acid

该化合物是主要用于治疗高血压和心脏衰竭的抗抑制酶(ACE),主要用于治疗高血压和心脏衰竭,其作用是阻止将血管活性I转换为血管活性II,从而降低外围血管抗药性和降低血压. Trendolapril是作为辅助药物施用,肝脏中水解成其活性形态Trandolaprilat,其关键优点包括延长半衰期,允许每天服一次剂量,并显示在改善心血管结果方面的效果.该药物还因其有利的安全特征而得到注意,其不良效应的发生率低于其他血管活性抑制剂.该药物通常为需要长期抗体抗药性治疗的病人提供处方.

结构式图片

MSDS等安全信息

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号82717-90-6 八氢吲哚-2-羧酸苄酯 | CAS号82717-96-2 N-[1-(S)-乙氧羰基-3... | CAS号98677-37-3 替诺拉普利苄基酯 | CAS号145641-35-6 (2S,3aR,7aS)-八氢... | CAS号114192-42-6 N-[(S)-1-carbet... | CAS号82717-97-3 °Ctahydroindole... | CAS号84793-24-8 N-[1-(S)-乙氧羰基-3... | CAS号145438-94-4 L-(2S,3aR,7aS)-... | CAS号881637-74-7 (2S,3aR,7aS)-pe... | CAS号80828-13-3 八氢-1H-吲哚-2-羧酸 | CAS号82717-96-2 N-[1-(S)-乙氧羰基-3...

合成工艺路线路线简述

  • 98677-37-3 = 87679-37-6
    反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Ethanol; 2 H,Rt
    标题:Synthesis Of Trandolapril
    作者:Fang,Zheng; Et Al
    参考文献:Zhongguo Yaoxue Zazhi (Beijing 日期:2008 卷标:43(8) 页码:632-635]

    1471311-77-9 = 87679-37-6 [标题:Reaction Conditions
    标题:Organocatalytic Michael Addition/intramolecular Julia-Kocienski Olefination For The Preparation Of Nitrocyclohexenes
    作者:Rodrigo,Eduardo; Et Al
    参考文献:Journal Of Organic Chemistry 日期:2013 卷标:78(21) 页码:10737-10746]

    853269-34-8 = 87679-37-6 [标题:Reaction Conditions
    标题:Stereospecific Synthesis Of Cis-2,5-Disubstituted Pyrrolidines Via N,O-Acetals Formed By Hydroamination Cyclization-Hydroalkoxylation Of Homopropargylic Sulfonamides In Hfip
    作者:Wang,Weilin; Et Al
    参考文献:Journal Of Organic Chemistry 日期:2020 卷标:85(11) 页码:7045-7059]

    100-51-6 + 87679-58-1 = 87679-37-6
    反应条件:1.1 Reagents: Thionyl Chloride; 1 H,0 °C; 12 H,Rt2.1 Reagents: 1H-Benzotriazole,Ethylmorpholine,Dicyclohexylcarbodiimide Solvents: Dimethylformamide; 0 °C; 3.5 H,20 - 25 °C3.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Ethanol; 2 H,Rt
    标题:Synthesis Of Trandolapril
    作者:Fang,Zheng; Et Al
    参考文献:Zhongguo Yaoxue Zazhi (Beijing 日期:2008 卷标:43(8) 页码:632-635]

    2304837-57-6 = 87679-37-6
    反应条件:1.1 Reagents: Trifluoroacetic Acid Solvents: Dichloromethane; 30 Min,0 °C
    标题:A Stereoselective Synthesis Of The Ace Inhibitor Trandolapril
    作者:Chiha,Slim; Et Al
    参考文献:Synlett 日期:2019 卷标:30(7) 页码:813-816]

    82717-96-2 + 620973-54-8 = 87679-37-6
    反应条件:1.1 Reagents: 1H-Benzotriazole,Ethylmorpholine,Dicyclohexylcarbodiimide Solvents: Dimethylformamide; 0 °C; 3.5 H,20 - 25 °C2.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Ethanol; 2 H,Rt
    标题:Synthesis Of Trandolapril
    作者:Fang,Zheng; Et Al
    参考文献:Zhongguo Yaoxue Zazhi (Beijing 日期:2008 卷标:43(8) 页码:632-635]

    144540-75-0 + 84793-24-8 = 87679-37-6
    反应条件:1.1 Reagents: Triethylamine Solvents: Dichloromethane; 1.5 H,5 °C1.2 Reagents: Water1.3 Reagents: Diisopropyl Ether; 30 Min
    标题:Synthesis Of (2S,3Ar,7As)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-Phenylpropyl]Amino]-1-Oxopropyl]Octahydro-1H-Indole-2-Carboxylic Acid (Trandolapril)
    作者:Li,Jianhua; Et Al
    参考文献:Zhongguo Yiyao Gongye Zazhi 日期:2007 卷标:38(7) 页码:465-467
Tert-Butyl (2S,3Ar,7As)-1-(((S)-1-Ethoxy-1-Oxo-4-Phenylbutan-2-yl)-L-Alanyl)octahydro-1H-Indole-2-Carboxylate置于三氟乙酸体系中,用 二氯甲烷 作为反应溶剂,化学反应 0.5H,以97%的收率获得产物群多普利
参考文献:Ace抑制剂群多普利的立体选择性合成
标题:Ace抑制剂群多普利的立体选择性合成
摘要:实现了对映纯八氢吲哚结构单元的概念新颖和立体选择性合成,并将其转化为 Ace 抑制剂群多普利.关键步骤包括受保护的 L-焦谷氨酸衍生物的 α-烯丙基化,高度非对映选择性的 Hosomi-Sakurai 反应和 Ru 催化的 4,5-二烯丙基化脯氨酸的闭环复分解.这样,群多普利的合成以 25% 的总产率(12 步)有效实现.
DOI:10.1055/s-0037-1612306

海关参考信息

专利信息


专利号:US-9353057-B2
优先权日:2003-12-30
标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
权利人:XENOPORT INC
摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

专利号:US-10973847-B2
优先权日:2017-06-30
标题 :Core-to-surface polymerization for the synthesis of star polymers and uses thereof
发明人:JOHNSON JEREMIAH A; GOLDER MATTHEW R
权利人:MASSACHUSETTS INST TECHNOLOGY
摘要:Disclosed are methods, compositions, reagents, systems, and kits to prepare star polymers, as well as compositions and uses thereof. Various embodiments show that synthesis of these polymers contain low metal concentration to provide polymers for diverse biomedical applications including in vivo applications.

专利号:US-7973173-B2
优先权日:2005-07-05
标 题:Process for the synthesis of an ACE inhibitor
发明人:KANKAN RAJENDRA NARAYANRAO; RAO DHARMARAJ RAMACHANDRA; PHULL MANJINDER SINGH; SAWANT ASHWINI; BIRARI DILIP RAMDAS
权利人:CIPLA LTD
摘要:A process for the synthesis of trandolapril which comprises condensing N—[I—(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanine N-carboxyanhydride with trans octahydro-1H-indole-2-carboxylic acid in a first organic solvent comprising a water immiscible inert organic solvent and in the presence of a base, and isolating trandolapril from a second organic solvent. N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanine N-carboxyanhydride may also be condensed with (2S,3aR,7aS) octahydro-1H-indole-2-carboxylic acid in a first organic solvent and in the presence of a base, and trandolapril isolated. There is also provided a process for the resolution of racemic trans octahydro-1H-indole-2-carboxylc acid.

专利号:EP-1724260-B1
优先权日:2005-05-06
标题:Process for the synthesis of (2S, 3aR, 7aS)octahydroindole-2-carboxylic acid and its conversion to trandolapril
发明人:AKHTAR HAIDER; RAMESH BABU POTLURI; VENKATA SUBHRAMANIAN HARIHARAK; HARI PRASSAD KODALI
权利人:SOCHINAZ SA
摘要:The present invention describes a novel method for the synthesis of (2S,3aR,7aS)-octahydroindole-2-carboxylic acid of formula III nusing a new intermediate of formula II nand conversion of the product of formula-III to trandolapril of formula I

专利号:US-7094920-B2
优先权日:2001-05-21
标 题 :Stereoselective synthesis of 2-hydroxy-4-phenylbutyric acid esters
发明人:TIKARE RAVEENDRA KHANDURAO
权利人:FERMENTA BIOTECH LTD
摘要:A process is described for the stereospecific preparation of an ester of formula (I): wherein * signifies the (R) stereoisomer; R 1 is selected from C 1-6 alkyl, preferably ethyl; and R 2 is hydrogen, a protecting group or a leaving group which process comprises reaction of a nitrile of formula (II): wherein * signifies the (R) stereoisonomer; and Ph is the phenyl group C 6 H 5 with a solution of an inorganic acid in an alcohol and optional conversion of the compound of formula (I) wherein R 2 is H so prepared to any other desired compound of formula (I) by standard methods in the art. The compounds of formula (I) are chiral esters, useful as intermediates in the synthesis of the family of acetylcholine esterase (ACE) inhibitors known as “prilsâ€?, such as lisinopril, cilazapril, enalapril, benazepril, ramipril, delapril, enalaprilat, imidapril, spirapril, trandolapril and others.n n*n nPh-CH 2 —CH 2 —CH(OR 2 )—COOR 1   (I)n n*n nPh-CH 2 —CH 2 —CH(H)—CN  (II)

专利号:US-8431712-B2
优先权日:2004-02-09
标 题 :Methods for the synthesis of pyridoxamine
发明人:KHALIFAH RAJA G; KEILITZ ROLAND; KOELLNER CHRISTOPH; DEGENHARDT THORSTEN; BRAND STEPHEN ROBERT
权利人:KHALIFAH RAJA G; KEILITZ ROLAND; KOELLNER CHRISTOPH; DEGENHARDT THORSTEN; BRAND STEPHEN ROBERT; NEPHROGENEX INC
摘要:The invention provides non-oxidative methods for the large scale manufacture of pyridoxamine (I) (4-aminomethyl-3-hydroxy-5-hydroxymethyl-2-methylpyridine): n nand salts thereof.n nThe invention also provides intermediate compounds for the synthesis of pyridoxamine, as well as compositions and methods for the treatment and/or prevention of conditions associated with the formation of post-Amadori advanced glycation end-products.
台州市科瑞生物技术有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.pharm-intermediates.com
企业联系电话:0576-88813233👤
📞台州市科瑞生物技术有限公司 ⚠️参考联系方式
联系人:金崇光
电话:0576-88813233
手机:13396860566
传真:0576-88813233
邮箱:sales@pharm-intermediates.com
通信地址: 台州市开发大道东段288号
邮编: 318000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:台州市开发大道东段288号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Cohen V, Jellinek SP, Fancher L, Sangwan G, Wakslak M, Marquart E, Farahani C. Tarka® (trandolapril/verapamil hydrochloride extended-release) overdose. J Emerg Med. 2011 Mar;40(3):291-5. doi: 10.1016/j.jemermed.2008.10.015. Epub 2009 Feb 26. Review. Review.
3: Sharma SK, Ruggenenti P, Remuzzi G. Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination. Vasc Health Risk Manag. 2007;3(4):453-65. Review.
4: Muijsers RB, Curran MP, Perry CM. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension. Drugs. 2002;62(17):2539-67. Review. Review. Review. Croatian. Review. Review. Review. Review. Review. Review.

合成参考文献


参考文献:10.1038/ncb3255
摘要:Lin R, Elf S, Shan C, Kang HB, Ji Q, Zhou L, Hitosugi T, Zhang L, Zhang S, Seo JH, Xie J, Tucker M, Gu TL, Sudderth J, Jiang L, Mitsche M, DeBerardinis RJ, Wu S, Li Y, Mao H, Chen PR, Wang D, Chen GZ, Hurwitz SJ, Lonial S, Arellano ML, Khoury HJ, Khuri FR, Lee BH, Lei Q, Brat DJ, Ye K, Boggon TJ, He C, Kang S, Fan J, Chen J. 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. Nat Cell Biol. 2015 Nov;17(11):1484–96.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知